Merry Life Launches Global Phase II Trial of TML-6, The First Drug Targeted at Autolysosome pathway for Therapy of Alzheimer’s Disease
TAINAN, June 13, 2025 /PRNewswire/ -- Merry Life Biomedical Company announces the…
FOBI AI Inc. Announces Closing of the Sale of German Subsidiary
June 12, 2025 16:53 ET Â | Source: Fobi AI Inc. Vancouver, BC,…
Draganfly Announces Closing of US$13.75 Million Public Offering
Saskatoon, SK., June 12, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO)…
HYCROFT ANNOUNCES PRICING AND UPSIZING OF PUBLIC OFFERING OF UNITS
WINNEMUCCA, Nev., June 12, 2025 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq:…
Desay Battery Unveils Innovative Energy Storage Solutions at SNEC PV+ Expo, Announces Strategic Partnership with Turkish Energy Leader Demir Enerji
HUIZHOU, China, June 12, 2025 /PRNewswire/ -- Desay Battery, a global leader…
Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics
Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading…
Glucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
1-for-60 reverse stock split to become effective as of the opening of…
RadioMedix Debuts Proprietary bench top Pb Generator to Support Targeted Alpha Therapy Development
New bench top ²¹²Pb generator to expand clinical-grade isotope supply for targeted…
Sharecare introduces new interactive solutions to elevate health literacy and increase condition-specific treatment adherence
Utilizing augmented reality, artificial intelligence, and time-based visualization, Sharecare’s newest innovative tools…
LANZAJET EXPANDS PARTNERSHIP WITH MICROSOFT TO STRENGTHEN THE COMPANY’S GLOBAL GROWTH
This agreement deepens multi-level collaboration with Microsoft across climate investment, renewable fuel…